CFGS
QTTB icon

Concourse Financial Group Securities’s Q32 Bio QTTB Stock Holding History

Concourse Financial Group Securities’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-20
Closed -$2.5K – 2452
2021
Q1 		$3K Hold
20
– – ﹤0.01% 2095
2020
Q4 		$4K Hold
20
– – ﹤0.01% 1997
2020
Q3 		$4K Buy
+20
New +$4.48K ﹤0.01% 1897

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Concourse Financial Group Securities's QTTB Position: Q2 2021 in Review

Concourse Financial Group Securities sold out of Q32 Bio (QTTB) in Q2 2021, closing a stake of 20 shares — an estimated $2.5K sold.

Concourse Financial Group Securities first reported a position in QTTB in Q3 2020 and held it in 3 quarters. The position peaked at $4K in Q4 2020. 118 funds tracked by Wall St. Rank hold QTTB as of Q2 2021.

  • Concourse Financial Group Securities reported no remaining Q32 Bio position as of Q2 2021 after selling out during the quarter.
  • Concourse Financial Group Securities sold 20 Q32 Bio shares in Q2 2021, an estimated $2.5K.
  • Concourse Financial Group Securities first reported a position in Q32 Bio in Q3 2020 and held it in 3 quarters.
  • Concourse Financial Group Securities's Q32 Bio position peaked at $4K in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2021.

Based on Concourse Financial Group Securities's 13F filing for Q2 2021, filed 13 Aug 2021.